Jury Awards $130M In Wyeth Prempro Trial

Law360, New York (October 11, 2007, 12:00 AM EDT) -- Drug maker Wyeth Pharmaceuticals Inc. has lost a third trial over its controversial hormone replacement treatment, with a Nevada jury on Wednesday awarding $134.5 million to three women who blamed the drug for their breast cancer.

After a four-week trial and just two days deliberation the state court jury in Reno returned their verdict Wednesday afternoon, finding that Wyeth's menopause drugs Prempro and Premarin were defective and that the pharmaceutical giant was negligent in its marketing and selling of the products. Drug manufacturer Pfizer Inc. had...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.